-The Hindu The outgoing CEA also batted for the lateral entry of talent into the government The compensation payable to the States for revenue loss arising due to GST is just ?5,000 crore, far lower than was estimated, according to Chief Economic Adviser Arvind Subramanian. In a candid interview to The Hindu, the outgoing CEA also batted for the lateral entry of talent into the government, saying that it was a “no brainer”...

-Financial Express For sustainable growth, Rural India’s squeezing purchasing power needs immediate attention New Delhi: The Reserve Bank of India’s (RBI) unanimous call for a 25-basis-point rate hike after four years was primarily driven by the strengthening core inflation as well as the rising household inflationary expectations. Since the April Monetary Policy Committee meeting, there have been some significant macro developments, mainly on four counts. First, the global crude oil prices have risen...

-The Indian Express Only 21 per cent of India’s milk production gets processed through the organised sector and the rest passes through unorganised small players. And that’s where the crisis is most intense. Farmers, who had high expectations from the Narendra Modi government, are a disillusioned lot today. Market prices of several crops have remained well below their minimum support prices (MSPs). Moreover, milk prices have fallen by 20 per cent...

-The Hindu Business Line The Ayushman Bharat programme must aim to reverse poverty caused by healthcare expenses The state of India’s healthcare system is somewhat dichotomous — the country is a global supplier of life-saving, affordable and good quality generic medicines, yet lakhs of families are driven into poverty because they are forced to spend much of their earnings and savings on medications to treat chronic and life-threatening diseases. The poor, particularly,...

-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...